Joseph Fraser Glickman

Title: Joseph Fraser Glickman: Innovator in Cancer Treatment

Introduction

Joseph Fraser Glickman is a notable inventor based in New York, NY (US), recognized for his contributions to cancer treatment. He holds three patents that focus on innovative methods for combating pancreatic and related cancers. His work is significant in the field of oncology, particularly in developing therapies that target specific cancer cell growth mechanisms.

Latest Patents

Glickman's latest patents include methods for inhibiting the growth of pancreatic cancer cells and other cancer cells driven by Sonic hedgehog. These methods involve exposing the cells to 5-acyl-6,7-dihydrothieno[3,2-c]pyridines, which are detailed in his patent filings. His research aims to provide new avenues for treatment in a field that desperately needs effective solutions.

Career Highlights

Throughout his career, Glickman has worked with prestigious institutions such as Memorial Sloan Kettering Cancer Center and The Rockefeller University. His experience in these renowned organizations has allowed him to collaborate with leading experts in cancer research and treatment.

Collaborations

Some of Glickman's notable coworkers include Marilyn D Resh and Elissaveta Petrova. Their collaborative efforts have contributed to advancements in cancer research and therapeutic strategies.

Conclusion

Joseph Fraser Glickman is a prominent figure in the field of cancer treatment, with a focus on innovative methods to inhibit cancer cell growth. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.